Navigating the path: Advice to physician-scientists on choosing a clinical specialty
- Professor of Medicine, Senior Associate Dean for MD-PhD Education, Icahn School of Medicine at Mount Sinai, United States
- Associate Dean and Professor of Neurology, UT Health San Antonio, United States
- Associate Dean for Physician-Scientist Education, Professor, Department of Laboratory Medicine and Pathology, University of Washington School of Medicine, United States
- Associate Dean for Medical Education, Associate Professor of Medicine and Pharmacology, University of Colorado School of Medicine, United States
- Cardiovascular Pathologist, Office of Chief Medical Examiner of the City of New York, United States
- Professor, Dermatology, Vice Chair of Research in the Department of Dermatology, UCSF, United States
- Professor of Surgery, Assistant Chair of Innovation, Associate Director of MD-PhD Training Program, University of Florida, United States
- Professor of Emergency Medicine, Anesthesia and Critical Care, and Epidemiology, University of Iowa Carver College of Medicine, United States
- Matthew J. Wilson, Professor of Radiology, Vice-Chair for Research, Department of Radiology, Associate Director of Education and Training, Abramson Cancer Center, University of Pennsylvania, United States
- Professor of Pediatrics, Endowed Professor of Pediatric Liver Research, the Associate Chief of the Division of Pediatric Hepatology, Icahn School of Medicine at Mount Sinai, United States
- Professor of Medicine and of Microbiology & Immunology, Weill Cornell Medicine, United States
- Henrik H. Bendixen Professor of Anesthesiology, Vice Chair for Research, Department of Anesthesiology, Columbia University, United States
- Associate Dean, Physician Scientist Education and Training, Professor of Medicine, Vanderbilt University Medical Center, Veterans Administration Health System, Vanderbilt Ingram Cancer Center, United States
Figures
Figure 1
Decision-making framework for physician-scientists choosing a clinical specialty.
This figure presents a structured approach to specialty selection for physician-scientists, highlighting key considerations that inform an intentional and sustainable career choice. The framework emphasizes alignment of clinical and research interests, evaluation of research integration and training pathways, assessment of lifestyle and career sustainability factors, engagement with mentorship, and synthesis of these elements to support informed decision-making.
Tables
Table 1
Key decision factors for physician-scientists choosing a clinical specialty.
| Factor | Why it matters | What to look for | Potential red flags |
|---|---|---|---|
| Alignment of clinical specialty with research focus | Sustained success as a physician-scientist depends on the ability to generate clinically informed research questions and maintain access to relevant patient populations, tissues, or data | Clear conceptual or translational link between clinical field and research area; access to relevant patient cohorts, clinical trials, or biospecimens; established examples of physician-scientists in that field | Difficulty accessing relevant patient populations or data; research that is only tangentially related to clinical work; reliance on external collaborators for core aspects of research |
| Structure of clinical work and Its impact on research time | The intensity, unpredictability, and procedural demands of clinical practice directly influence the ability to sustain protected research time | Predictable or modular clinical schedules; ability to consolidate clinical time; flexibility in clinical effort; specialties with established norms supporting reduced clinical load for research-focused faculty | High procedural volume requirements to maintain competency; unpredictable call schedules; continuous longitudinal patient responsibilities that fragment research time; inability to reduce clinical effort |
| Availability of structured research pathways and mentorship | Early-career success is strongly influenced by access to structured training pathways and experienced physician-scientist mentors | Formal research tracks (e.g. ABIM Research Pathway, Holman Pathway); multiple NIH-funded investigators in the department; strong track record of trainees obtaining K awards and transitioning to faculty positions; culture of mentorship | Reliance on a single mentor; absence of structured research pathways; limited history of trainee success in research careers; lack of grant-writing or career development support |
| Institutional environment and culture | Institutional commitment is often more determinative than specialty alone in enabling long-term success as a physician-scientist | Departments with multiple R01-funded investigators; presence of T32 training grants; institutional bridge funding and startup support; leadership that values and protects physician-scientist careers; collaborative research environment | Departments primarily driven by clinical revenue (RVUs) with limited research infrastructure; lack of protected time enforcement; minimal NIH funding; absence of physician-scientists in leadership roles |
| Financial model and long-term sustainability | Financial pressures influence career decisions, effort allocation, and retention in research | Transparent compensation models that support protected research time; startup packages, bridge funding, and salary guarantees; access to loan repayment programs (e.g. NIH LRP); alignment between clinical effort and research expectations | Heavy reliance on clinical revenue to support salary; misalignment between expected research effort and financial support; lack of institutional investment in early-career investigators; financial pressures that incentivize abandoning research |
Table 2
Physician scientist specialty choices, research integration, and funding opportunities across residency and fellowship training.
| Specialty | % of MD-PhD grads (Akabas and Brass, 2019) | Structured research program during residency/fellowship | Nature of clinical practice | Research potential post-training | Common research areas |
|---|---|---|---|---|---|
| Internal medicine | 27% | ABIM Research Pathway (https://www.abim.org/certification/policies/research-pathway/policies-requirements/) | Broad, inpatient/outpatient, chronic disease management | Strong NIH funding (K/R awards), academic research careers well-established, ABIM physician-scientist pathway | Immunology, infectious diseases, cardiovascular disease, cancer biology, respiratory diseases, GI pathophysiology |
| Pediatrics | 13% | ABP Integrated Research pathway (https://www.abp.org/content/integrated-research-pathway-irp) | Outpatient and inpatient, developmental and longitudinal focus | NIH-supported research pathways, subspecialty fellowships integrate research | Developmental biology, cancer biology, infectious disease, immunology, inborn errors of metabolism, genetics of inherited and rare diseases |
| Pathology | 10% | ABPath Physician-Scientist Research Pathway (https://abpath.org/physician-scientist-research-pathway/) | Laboratory-based, diagnostics, molecular testing, typically both anatomic Pathology (AP, tissue diagnosis) and clinical Pathology (CP, clinical laboratory testing) but sometimes just one or the other is completed. CP can be the shortest of all residencies (two-years) | Lab-based research seamlessly integrates into clinical work; NIH and industry funding prevalent | Cancer biology, molecular diagnostics, immunopathology, broad pathophysiologic investigations |
| Neurology | 9% | Many institutions offer research tracks which provide a combined residency program in Neurology and Psychiatry, emphasizing research training | Inpatient and outpatient, complex chronic disease focus, Neuro-ICU and procedural tracks exist, clinic-based | NIH funding for neuroscience, translational and clinical research, research-heavy fellowships available | Neuroscience, stroke, neurodegeneration, neuroimmunology, epilepsy, movement disorders |
| Radiology | 5% | ABR Holman Research Pathway (https://www.theabr.org/diagnostic-radiology/initial-certification/alternate-pathways/holman-research-pathway). Some programs offer dedicated research tracks, often supported by NIBIB T32s | Technology-driven, imaging-based diagnosis, procedural approaches (interventional radiology (IR)) and targeted therapy (IR and nuclear medicine) | Research in imaging, imaging technology, AI applications, application of imaging to translational research, NIH, foundation, and industry funding sources available | Imaging and image-guided therapy methods, biomedical engineering, applied physics and chemistry, molecular imaging and therapy, applications of imaging to specific disease biology |
| Psychiatry | 5% | Many institutions offer specialized training within general residency dedicated to nurturing future clinical and basic neuropsychiatric researchers. | Outpatient-focused, long-term patient care | NIH (NIMH) funding opportunities for neuropsychiatric research; research-focused career pathways | Neuroscience, neuropsychiatric disorders, addiction research |
| Surgery (all) | 12% | Some programs offer dedicated research years or tracks, though not universally standardized. | Procedural, high-intensity, acute care | Limited protected research time; research opportunities available but require leadership negotiations for protected time and effort to integrate into career. For NIH K awards, surgeon-scientists with active surgical duties can request a reduced effort of 50% | Transplantation/Immunology, surgical oncology, regenerative medicine, trauma/acute care/sepsis, neurosurgery, vascular surgery, burn/wound healing |
| Medical genetics | 1% | ABMGG (https://www.abmgg.org/initial-certification/certification-pathways/) | Consultation-based, highly specialized. Often combined with medicine, pediatrics, or Ob/Gyn, sometimes neurology and pathology | Strong NIH and industry support; translational genomics and precision medicine research expanding rapidly | Genomics, rare disease research, precision medicine |
| Derm. | 3% | Certain institutions offer research-focused fellowships or integrated research tracks during residency. | Outpatient with inpatient consult opportunities. Opportunity for small and large procedures. Average practice has a mix of cutaneous oncology, immunology, autoimmunity, and aesthetics | NIH, foundation, and industry funding available, including CDAs; translational research opportunities exist | Immunology, microbiology, skin cancer, neurobiology, stem cell and stromal cell biology, AI, epidemiology, health disparities |
| Radiation oncology | 4% | Many programs offer dedicated research time or tracks; specifics vary by institution (https://www.acgme.org/specialties/the-holman-pathway). | Procedural, oncology-focused, technology-driven | NIH and private funding for cancer research; translational/clinical research integrated into practice. | Cancer biology, radiation therapy research |
| Family medicine | <1% | Limited Formal Research Tracks: Research opportunities may be available but are often less structured compared to other specialties. | Outpatient primary care, broad-spectrum medicine | Few research-intensive career pathways; NIH funding is uncommon. | Community health, health disparities, preventative medicine |
| Ob/Gyn | <1% | Some institutions offer research tracks or fellowships focusing on areas like maternal-fetal medicine. | Procedural and medical, maternal-fetal focus | Research exists in maternal-fetal medicine and gynecologic oncology, but protected research time is limited. | Reproductive biology, maternal-fetal medicine, gynecologic oncology |
| Ophthalm. | 4% | Some programs offer integrated research training during residency; availability varies by institution. | Procedural, vision-focused, outpatient | NEI (NIH) funding strong; vision science research well-supported. | Vision science, retinal disease, corneal research |
Table 3
Comparison of research track and categorical residency pathways using internal medicine as an example.
| Key features | Research track | Categorical track |
|---|---|---|
| Primary focus | Balances clinical training with early transition to protected research time | Primarily focused on clinical training |
| Structure | Integrates significant research time within fellowship; protected time for research built into the training plan. Includes built-in mentorship with clear expectations for faculty transition. Research-focused institutions often provide structured pathways leading to junior faculty positions | Full-time clinical training with optional research electives |
| Duration | 2 years of residency, 3+years of fellowship (with embedded post-doctoral training) | 3 years of residency, 3 years of fellowship |
| Eligibility | Requires strong research experience and a clear commitment to a physician-scientist career. Board eligibility for Internal Medicine in PGY-4 or PGY-5, subspecialty boards in PGY-6 or later | Open to all applicants, requires completion of standard residency and fellowship clinical requirements before board certification |
| Common specialties | Internal Medicine (ABIM Research Pathway), Pediatrics, Neurology, Pathology, Radiology | All medical specialties |
| Research Commitment | ≥80% required research effort during later fellowship to early faculty years | Usual ~80% research effort for ~1 year |
| Funding support | ≥80% research effort during later fellowship years; often includes NIH R38, R25, F32, or T32 support with expectation of application for mentor career award at the end of the training | Centers for Medicare and Medicaid Services-based funding; research funding may be available for those pursuing academic careers |
| Career outcomes | High proportion of graduates enter academic medicine (physician-scientist careers, faculty roles, NIH-funded research) | Majority enter clinical practice, though some continue in academic medicine |
| Application considerations | Requires strong research experience, commitment to physician-scientist training, and alignment with institution’s research mission | Field-specific competitiveness features |
| Mentorship and support | Structured mentorship with dedicated physician-scientist training programs, institutional funding, and NIH support | Highly dependent on individual institution and faculty mentors |
| Effort and activities by PGY year (sample based on Internal Medicine timeline) | ||
| PGY1 | Intern year – 100% clinical responsibilities, inpatient-heavy | Intern year – 100% clinical responsibilities, inpatient-heavy |
| PGY2 | Resident (first year) ~80–90% clinical, 10–20% research (depending on program structure); initial research planning Fellowship match | Resident (first year) ~80–90% clinical, 10–20% research (depending on program structure) with most having some scholarly requirement |
| PGY3 | Fellowship year 1 100% clinical subspecialty training board-eligible for IM boards | Resident (second year) ~80–90% clinical, 10–20% research (depending on program structure), most with scholarly requirement fellowship match board-eligible for IM boards |
| PGY4 | Fellowship year 2 80% research <20% clinical | Fellowship year 1 100% clinical subspecialty training |
| PGY5 | Fellowship year 3 80% research <20% clinical board-eligible for subspecialty boards | Fellowship year 2 80% research <20% clinical board-eligible for subspecialty boards |
| PGY6 | Fellowship year 4 80% research <20% clinical | Fellowship year 3 (80% research <20% clinical) |
| PGY7 | First faculty or other position – requires 80% research commitment for NIH career development awards (e.g. K08, K23, K99/R00) | First faculty or other position |
Table 4
Career stages and key considerations for physician-scientists.
| Career stage | Primary focus | Key challenges | Opportunities |
|---|---|---|---|
| Early career (residency, fellowship, first faculty position) | Establishing clinical competence, securing protected research time, and developing independent research projects | High clinical workload, obtaining first grants, managing dual training demands | Research-track residencies/fellowships (ABIM Research Pathway, Integrated Research Pathways in Pediatrics, Neurology, Pathology, Holman Pathway), NIH-funded career development awards (F32, K-awards) |
| Mid-career (first independent research grant to established investigator) | Balancing clinical, research, and administrative responsibilities; mentoring junior researchers; securing sustained funding | Time management, maintaining protected research time, transitioning to leadership roles | NIH R01 funding, leadership positions in research divisions, and industry collaborations |
| Late career (established investigator to senior leadership and mentorship) | Mentorship, institutional leadership, high-level advocacy for physician scientists | Sustaining research momentum, shifting toward administrative responsibilities, and succession planning | Directing training programs, serving on NIH study sections, and guiding institutional policy |
Download links
A two-part list of links to download the article, or parts of the article, in various formats.
Downloads (link to download the article as PDF)
Open citations (links to open the citations from this article in various online reference manager services)
Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)
Navigating the path: Advice to physician-scientists on choosing a clinical specialty
eLife 15:RP110448.
https://doi.org/10.7554/eLife.110448.3
